GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » FCF Yield %

BioPharma Credit (LSE:BPCR) FCF Yield % : 17.87 (As of May. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BioPharma Credit's Trailing 12-Month Free Cash Flow is $184.3 Mil, and Market Cap is $1,031.4 Mil. Therefore, BioPharma Credit's FCF Yield % for today is 17.87%.

The historical rank and industry rank for BioPharma Credit's FCF Yield % or its related term are showing as below:

LSE:BPCR' s FCF Yield % Range Over the Past 10 Years
Min: 4.23   Med: 7.34   Max: 17.87
Current: 17.87


During the past 7 years, the highest FCF Yield % of BioPharma Credit was 17.87%. The lowest was 4.23%. And the median was 7.34%.

LSE:BPCR's FCF Yield % is ranked better than
87.08% of 1594 companies
in the Asset Management industry
Industry Median: 3.095 vs LSE:BPCR: 17.87

BioPharma Credit's FCF Margin % for the quarter that ended in Dec. 2022 was 140.22%.


BioPharma Credit FCF Yield % Historical Data

The historical data trend for BioPharma Credit's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit FCF Yield % Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial 9.38 4.24 7.25 14.70 11.26

BioPharma Credit Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.31 9.21 3.52 25.78 -

Competitive Comparison of BioPharma Credit's FCF Yield %

For the Asset Management subindustry, BioPharma Credit's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's FCF Yield % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's FCF Yield % falls into.



BioPharma Credit FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BioPharma Credit's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=123.182 / 1094.2512
=11.26%

BioPharma Credit's annualized FCF Yield % for the quarter that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=161.526 * 2 / 1253.221
=25.78%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioPharma Credit FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BioPharma Credit FCF Yield % Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit (LSE:BPCR) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines